SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 42 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,461,659 | -4.5% | 4,460,000 | -5.8% | 0.01% | -10.0% |
| Q4 2022 | $4,669,483 | +1.0% | 4,737,000 | +0.5% | 0.01% | 0.0% |
| Q3 2022 | $4,624,000 | -5.7% | 4,715,000 | -6.7% | 0.01% | 0.0% |
| Q2 2022 | $4,906,000 | +8.9% | 5,053,000 | +9.9% | 0.01% | +25.0% |
| Q1 2022 | $4,507,000 | -1.4% | 4,599,000 | 0.0% | 0.01% | +14.3% |
| Q4 2021 | $4,570,000 | +9.4% | 4,599,000 | +8.9% | 0.01% | 0.0% |
| Q3 2021 | $4,179,000 | +11.2% | 4,223,000 | +11.5% | 0.01% | +16.7% |
| Q2 2021 | $3,757,000 | -7.0% | 3,786,000 | -11.2% | 0.01% | -25.0% |
| Q4 2020 | $4,041,000 | +99.2% | 4,262,000 | +93.5% | 0.01% | +100.0% |
| Q3 2020 | $2,029,000 | -46.2% | 2,203,000 | -48.6% | 0.00% | -50.0% |
| Q2 2020 | $3,768,000 | – | 4,282,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 45,402,000 | $45,147,000 | 3.42% |
| Ayrton Capital LLC | 2,000,000 | $1,982,000 | 1.87% |
| Radcliffe Capital Management, L.P. | 69,010,000 | $68,018,000 | 1.78% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 74,027,000 | $73,675,000 | 1.54% |
| DeepCurrents Investment Group LLC | 33,182,000 | $32,736,000 | 1.02% |
| Penn Mutual Asset Management | 675 | $665,000 | 0.71% |
| SHENKMAN CAPITAL MANAGEMENT INC | 7,897,000 | $7,533,000 | 0.51% |
| OAKTREE CAPITAL MANAGEMENT LP | 19,901,000 | $19,714,000 | 0.22% |
| WOLVERINE ASSET MANAGEMENT LLC | 9,940,000 | $9,858,000 | 0.09% |
| Jefferies Group LLC | 12,740,000 | $12,658,285 | 0.07% |